Next Article in Journal
Emerging Functional Imaging Biomarkers of Tumour Responses to Radiotherapy
Next Article in Special Issue
The Efficacy of miR-20a as a Diagnostic and Prognostic Biomarker for Colorectal Cancer: A Systematic Review and Meta-Analysis
Previous Article in Journal
Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence
Previous Article in Special Issue
Prognostic Impact of Tumor-Infiltrating Lymphocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer
Article

3D Mammary Epithelial Cell Models: A Goldmine of DCIS Biomarkers and Morphogenetic Mechanisms

Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA
*
Author to whom correspondence should be addressed.
Cancers 2019, 11(2), 130; https://doi.org/10.3390/cancers11020130
Received: 10 December 2018 / Revised: 14 January 2019 / Accepted: 18 January 2019 / Published: 23 January 2019
(This article belongs to the Special Issue Cancer Biomarkers)
Breast ductal carcinoma in situ (DCIS) has been typically recognized by pathologists on the basis of aberrant mammary duct morphology. Thus, there are increasing efforts to detect DCIS biomarkers and druggable targets. In this study we focused on the molecular mechanism involving Annexin A8 (ANXA8), a Ca2+ and phospholipid binding protein, which is regulated by all-trans Retinoic Acid (RA), and it is highly expressed in breast DCIS tissue samples relative to atypical ductal hyperplasia, and normal breast tissue. Using a panel of human mammary epithelial HME1 cell lines that share a common protein signature, and develop in vitro three dimensional (3D) “DCIS-like” amorphous structures, we identified by bioinformatics analysis protein-miRNA pairs, potentially involved in mammary morphogenetic mechanisms, including the ANXA8 mechanism. HME1 cells with genetic mutations hampering the physiological RA regulation of the RA receptor alpha (RARA) transcriptional function, but retain the RARA function controlling the PI3KCA-AKT signaling, develop 3D “DCIS-like” amorphous structures with upregulated ANXA8. Consistently, ectopic ANXA8 expression, by affecting the RARA transcriptional function, induced HME1 DCIS-like amorphous acini expressing phosphorylated AKT (P-AKT). Apparently, a RA-RARA-ANXA8 feedback loop fosters a vicious circle of aberrant morphogenesis. Interestingly, a few miRNAs regulated by RA are predicted to target ANXA8 mRNA. These miRNAs are candidate components of the RA-RARA-ANXA8 mechanism, and their deregulation might induce DCIS initiation. View Full-Text
Keywords: ductal carcinoma in situ (DCIS); 3D HME1 models; protein-miRNA pairs; DCIS biomarkers and morphogenetic mechanisms ductal carcinoma in situ (DCIS); 3D HME1 models; protein-miRNA pairs; DCIS biomarkers and morphogenetic mechanisms
Show Figures

Figure 1

MDPI and ACS Style

Rossetti, S.; Sacchi, N. 3D Mammary Epithelial Cell Models: A Goldmine of DCIS Biomarkers and Morphogenetic Mechanisms. Cancers 2019, 11, 130. https://doi.org/10.3390/cancers11020130

AMA Style

Rossetti S, Sacchi N. 3D Mammary Epithelial Cell Models: A Goldmine of DCIS Biomarkers and Morphogenetic Mechanisms. Cancers. 2019; 11(2):130. https://doi.org/10.3390/cancers11020130

Chicago/Turabian Style

Rossetti, Stefano, and Nicoletta Sacchi. 2019. "3D Mammary Epithelial Cell Models: A Goldmine of DCIS Biomarkers and Morphogenetic Mechanisms" Cancers 11, no. 2: 130. https://doi.org/10.3390/cancers11020130

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop